Coppola, A.; La Vaccara, V.; Farolfi, T.; Fiore, M.; Cammarata, R.; Ramella, S.; Coppola, R.; Caputo, D.
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. Biomedicines 2022, 10, 2091.
https://doi.org/10.3390/biomedicines10092091
AMA Style
Coppola A, La Vaccara V, Farolfi T, Fiore M, Cammarata R, Ramella S, Coppola R, Caputo D.
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. Biomedicines. 2022; 10(9):2091.
https://doi.org/10.3390/biomedicines10092091
Chicago/Turabian Style
Coppola, Alessandro, Vincenzo La Vaccara, Tommaso Farolfi, Michele Fiore, Roberto Cammarata, Sara Ramella, Roberto Coppola, and Damiano Caputo.
2022. "Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives" Biomedicines 10, no. 9: 2091.
https://doi.org/10.3390/biomedicines10092091
APA Style
Coppola, A., La Vaccara, V., Farolfi, T., Fiore, M., Cammarata, R., Ramella, S., Coppola, R., & Caputo, D.
(2022). Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. Biomedicines, 10(9), 2091.
https://doi.org/10.3390/biomedicines10092091